NKGen Biotech Inc
NKGN
Get informed when a big investor buys or sells
+ FollowMarket Cap$7.84M
Close$
$-1.27
2222.3% downside
Current Fair Value
2222.3% downsideOvervalued by 2222.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $7.84 Million |
|---|---|
| Enterprise Value | $23.52 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.54 |
| Beta | 0.65 |
| Outstanding Shares | 28,830,356 |
Return
| Return on Equity | 46.80% |
|---|---|
| Return on Assets | -148.68% |
| Return on Invested Capital | -4.24% |
Valuation & Multiples
| P/E Ratio | -0.12 |
|---|---|
| PEG | 0.03 |
| Price to Sales | - |
| Price to Book Ratio | -0.03 |
| Enterprise Value to Revenue | 36.08 |
| Enterprise Value to EBIT | 19.77 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.67 |
| Debt to Equity | -0.31 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
March 2, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 9.56%0% |
|---|---|
| Total Invested | $137,797▼ 54.55% |
| Investors Holding | 10% |
ESG Score
No data
About NKGen Biotech Inc
graf industrial corp is a blank check company. the company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more busine...